Accendra Health, Inc. ACH
NYSE
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -19.70M | -89.07M | -6.47M | -56.33M | -150.28M |
| Total Depreciation and Amortization | 38.92M | 65.70M | 61.74M | 29.87M | 64.10M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -44.10M | -43.97M | -46.31M | -114.86M | -103.86M |
| Change in Net Operating Assets | 7.47M | 41.33M | -59.05M | 209.50M | 17.52M |
| Cash from Operations | -17.41M | -26.01M | -50.08M | 68.19M | -172.52M |
| Capital Expenditure | -39.16M | -47.59M | -41.65M | -13.13M | -42.13M |
| Sale of Property, Plant, and Equipment | 13.32M | 15.30M | 96.42M | 24.60M | 18.37M |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | 324.26M | -- |
| Other Investing Activities | 31.61M | 1.04M | -844.00K | -50.72M | -15.70M |
| Cash from Investing | 5.77M | -31.25M | 53.93M | 285.00M | -39.46M |
| Total Debt Issued | 149.00M | 1.52B | 269.10M | 472.30M | 812.30M |
| Total Debt Repaid | -114.00M | -1.77B | -217.60M | -539.50M | -676.60M |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -3.52M | 0.00 |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -4.40M | -16.98M | -416.00K | -46.77M | 45.40M |
| Cash from Financing | 30.60M | -271.98M | 51.08M | -117.50M | 181.10M |
| Foreign Exchange rate Adjustments | 1.00K | 0.00 | -41.00K | 129.00K | -34.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 18.96M | -329.23M | 54.89M | 235.82M | -30.92M |